SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005536
Filing Date
2022-04-11
Accepted
2022-04-11 06:06:42
Documents
17
Period of Report
2022-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-20220407.htm   iXBRL 8-K 68735
2 EX-10.1 bdsx-ex10_1.htm EX-10.1 268449
3 EX-10.2 bdsx-ex10_2.htm EX-10.2 218659
4 EX-10.3 bdsx-ex10_3.htm EX-10.3 177012
5 EX-99.1 bdsx-ex99_1.htm EX-99.1 17826
6 GRAPHIC img189760734_0.jpg GRAPHIC 2870
  Complete submission text file 0000950170-22-005536.txt   983514

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsx-20220407.xsd EX-101.SCH 2488
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsx-20220407_lab.xml EX-101.LAB 18612
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsx-20220407_pre.xml EX-101.PRE 11596
11 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20220407_htm.xml XML 4886
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 22818418
SIC: 8071 Services-Medical Laboratories